Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway

Human Gene Therapy

Volumn 13, Issue 16, 2002, Pages 1945-1960

  Tsuburai, Takahiro ^a   Ishigatsubo, Yoshiaki ^a   Suzuki, Motoyoshi ^a   Nagashima, Yoji ^a   Suzuki, Shunsuke ^a   Inoue, Satoshi ^a   Hashiba, Tomonori ^a   Ueda, Atsuhisa ^a   Ikehara, Kunihiko ^a   Matsuse, Takeshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COMPLEMENTARY DNA; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; HEME OXYGENASE 1; DNA; FASL PROTEIN, MOUSE; HEME OXYGENASE; HMOX1 PROTEIN, MOUSE; HYDROXYPROLINE; LIGAND; MEMBRANE PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL MEDICINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DNA DAMAGE; DNA DETERMINATION; EPITHELIUM CELL; FIBROSIS; GENE EXPRESSION; IDIOPATHIC DISEASE; LUNG FIBROSIS; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RESPIRATORY EPITHELIUM; TARGET ORGAN; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; GENE TRANSFER; GENE VECTOR; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; LUNG; LUNG LAVAGE; METABOLISM; NICK END LABELING; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALIA; MURINAE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLEOMYCIN; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; DNA; DNA, COMPLEMENTARY; FAS LIGAND PROTEIN; FIBROSIS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HYDROXYPROLINE; IN SITU NICK-END LABELING; LIGANDS; LUNG; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 0036431777     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340260355356     Document Type: Article

References (61)

1. Aizawa, T., Ishizaka, N., Kurokawa, K., Nagai, R., Nakajima, H., Taguchi, J., and Ohno, M. (2001). Different effects of angiotensin II and catecholamine on renal cell apoptosis and proliferation in rats. Kidney Int. 59, 645-653.
2. American Thoracic Society. (2000). Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement from the American Thoracic Society and the European Respiratory Society. Am. J. Respir. Crit. Care Med. 161, 646-664.
3. Aoshiba, K., Yasui, S., Tamaoki, J., and Nagai, A. (2000). The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 162, 695-700.
4. Bett, A.J., Haddara, W., Prevec, L., and Graham, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. U.S.A. 91, 8802-8806.
5. Bienkowski, R.S., and Gotkin, M.G. (1995). Control of collagen deposition in mammalian lung. Proc. Soc. Exp. Biol. Med. 209, 118-140.
6. Broekelmann, T.J., Limper, A.H., Colby, T.V., and McDonald, J.A. (1991). Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. U.S.A. 88, 6642-6646.
7. Brouard, S., Otterbein, L.E., Anrather, J., Tobiasch, E., Bach, F.H., Choi, A.M., and Soares, M.P. (2000). Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192, 1015-1026.
8. Chen, E.S., Greenlee, B.M., Wills-Karp, M., and Moller, D.R. (2001). Attenuation of lung inflammation and fibrosis in interferon-T-deficient mice after intratracheal bleomycin. Am. J. Respir. Cell Mol. Biol. 24, 545-555.
9. Choi, A.M., and Alam, J. (1996). Heme oxygenase-l: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15, 9-19.
10. Elias, J.A., Freundlich, B., Kern, J.A., and Rosenbloom, J. (1990). Cytokine networks in the regulation of inflammation and fibrosis in lung. Chest 97, 1439-1445.
11. Gharaee-Kermani, M., McGarry, B., Lukacs, N., Huffnagle, G., Egan, R.W., and Phan, S.H. (1998). The role of IL-5 in bleomycin-induced pulmonary fibrosis. J. Leukoc. Biol. 64, 657-666.
12. Giri, S.N., Hyde, D.M., and Hollinger, M.A. (1993). Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice. Thorax 48, 959-966.
13. Graham, F.L., and Van der Eb, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
14. Gurujeyalakshmi, G., and Giri, S.N. (1995). Molecular mechanisms of antifibrotic effect of interferon γ in bleomycin-mouse model of lung fibrosis: Downregulation of TGF-β and procollagen I and HI gene expression. Exp. Lung Res. 21, 791-808.
15. Hagimoto, N., Kuwano, K., Miyazaki, H., Kunitake, R., Fujita, M., Kawasaki, M., Kaneko, Y., and Hara, N. (1997a). Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17, 272-278.
16. Hagimoto, N., Kuwano, K., Nomoto, Y., Kunitake, R., and Hara, N. (1997b). Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16, 91-101.
17. Hancock, W.W., Buelow, R., Sayegh, M.H., and Turka, L.A. (1998). Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med. 4, 1392-1396.
18. hashiba, T., suzuki, M., nagashima, Y., suzuki, S., inoue, S., tsuburai, T., matsuse, T., and ishigatsubo, Y. (2001). Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther. 8, 1499-1507.
19. Hersh, J., Crystal, R.G., and Bewlg, B. (1995). Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2, 124-131.
20. Hoyt, D.G., and Lazo, J.S. (1988). Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-β precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246, 765-771.
21. Inguaggiato, P., Gonzalez-Michaca, L., Croatt, A.J., Haggard, J.J., Alam, J., and Nath, K.A. (2001). Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int. 60, 2181-2191.
22. Inoue, S., Suzuki, M., Nagashima, Y., Suzuki, S., Hashiba, T., Tsuburai, T., Ikehara, K., Matsuse, T., and Ishigatsubo, Y. (2001). Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum. Gene Ther. 12, 967-979.
23. Katori, M., Buelow, R., Ke, B., Ma, J., Coito, A.J., Iyer, S., Southard, D., Busuttil, R.W., and Kupiec-weglinski, J.W. (2002). Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptofic pathway. Transplantation 73, 287-292.
24. Keane, M.P., Belperio, J.A., Burdick, M.D., and Strieter, R.M. (2001). IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L92-L97.
25. Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., Suda, T., Kunitake, R., Maeyama, T., Miyazaki, H., and Hara, N. (1999). Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104, 13-19.
26. Kuwano, K., Kunitake, R., Maeyama, T., Hagimoto, N., Kawasaki, M., Matsuba, T., Yoshimi, M., Inoshima, I., Yoshida, K., and Hara, N. (2001). Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L316-L325.
27. Lu, H.T., Yang D.D., Wysk, M., Gatii, E., Mellman, I., Davis, R.J., and Flavell, R.A. (1999). Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18, 1845-1857.
28. Maeyama, T., Kuwano, K., Kawasaki, M., Kunitake, R., Hagimoto, N., and Hara, N. (2001). Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L1128-L1137.
29. Maines, M.D. (1997). The heme oxygenase system: A regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517-554.
30. Manetti, R., Parronchi, P., Giudizi, M.G., Piccinni, M.P., Maggi, E., Trinchieri, G., and Romagnani, S. (1993). Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of lL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
31. Maulik, N., Engelman, D.T., Watanabe, M., Engelman, R.M., Rousou, J.A., Flack, J.E., III, Deaton, D.W., Gorbunov, N.V., Elsayed, N.M., Kagan, V.E., and Das, D.K. (1996a). Nitric oxide/carbon monoxide: A molecular switch for myocardial preservation during ischemia. Circulation 94, II398-II406.
32. Maulik, N., Sharma, H.S., and Das, D.K. (1996b). Induction of the haem oxygenase gene expression during the reperfusion of ischemic rat myocardium. J. Mol. Cell. Cardiol. 28, 1261-1270.
33. McKnight, A.J., Zimmer, G.J., Fogelman, I., Wolf, S.F., and Abbas, A.K. (1994). Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152, 2172-2179.
34. Melo, L.G., Agrawal, R., Zhang, L., Rezvani, M., Mangi, A.A., Ehsan, A., Griese, D.P., Dell'Acqua, G., Mann, M.J., Oyama, J., Yet, S.F., Layne, M.D., Perrella, M.A., and Dzau, V.J. (2002). Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105, 602-607.
35. Mishra, A., Doyle, N.A., and Martin, W.J.C. (2000). Bleomycin-mediated pulmonary toxicity: Evidence for a p53-mediated response. Am. J. Respir. Cell Mol. Biol. 22, 543-549.
36. Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K., and Iwamoto, I. (1999). Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest. 104, 5-11.
37. Nath, K.A. (1999). Heme oxygenase-l: A redoubtable response that limits reperfusion injury in the transplanted adipose liver. J. Clin. Invest. 104, 1485-1486.
38. Ortiz, L.A., Lasky, J., Hamilton, R.F., Jr., Holian, A., Hoyle, G.W., Banks, W., Peschon, J.J., Brody, A.R., Lungarella, G., and Friedman, M. (1998). Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp. Lung Res. 24, 721-743.
39. Otterbein, L.E., and Choi, A.M. (2000). Heme oxygenase: Colors of defense against cellular stress. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L1029-L1037.
40. Otterbein, L.E., Kolls, J.K., Mantell, L.L., Cook, J.L., Alam, J., and Choi, A.M. (1999a). Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest. 103, 1047-1054.
41. Otterbein, L.E., Mantell, L.L., and Choi, A.M. (1999b). Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol. 276, L688-L694.
42. Otterbein, L.E., Bach, F.H., Alam, J., Soares, M., Tao LU, H., Wysk M., Davis, R.J., Flavell, R.A., and Choi, A.M. (2000). Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6, 422-428.
43. Petrache, I., Otterbein, L.E., Alam, J., Wlegand, G.W., and Choi, A.M. (2000). Heme oxygenase-1 inhibits TNF-α-induced apoptosis in cultured fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L312-L319.
44. Piguet, P.F., and Vesin, C. (1994). Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7, 515-518.
45. Piguet, P.F., Collart, M.A., Grau, G.E., Kapanci, Y., and Vassalli, P. (1989). Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170, 655-663.
46. Pileggi, A., Molano, R.D., Berney, T., Cattan, P., Vizzardelli, C., Oliver, R., Fraker, C., Ricordi, C., Pastori, R.L., Bach, F.H., and Inverardi, L. (2001). Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50, 1983-1991.
47. Prior, C., and Haslam, P.L. (1992). In vivo levels and in vitro production of interferon-γ in fibrosing interstitial lung diseases. Clin. Exp. Immunol. 88, 280-287.
48. Ryter, S.W., Kvam, E., and Tyrrell, R.M. (2000). Heme oxygenase activity: Current methods and applications. Methods Mol. Biol. 99, 369-391.
49. Sato, K., Balla, J., Otterbein, L., Smith, R.N., Brouard, S., Lin, Y., Csizmadia, E., Sevigny, J., Robson, S.C., Vercellotti, G., Choi, A.M., Bach, F.H., and Soares, M.P. (2001). Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J. Immunol. 166, 4185-4194.
50. Shibahara, S., Muller, R., Taguchi, H., and Yoshida, T. (1985). Cloning and expression of cDNA for rat heme oxygenase. Proc. Natl. Acad. Sci. U.S.A. 82, 7865-7869.
51. Shiraishi, F., Curtis, L.M., Truong, L., Poss, K., Visner, G.A., Madsen, K., Nick, H.S., and Agarwal, A. (2000). Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am. J. Physiol. Renal Physiol. 278, F726-F736.
52. Sisson, T.H., Hattori, N., Xu, Y., and Simon, R.H. (1999). Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes. Hum. Gene Ther. 10, 2315-2323.
53. Soares, M.P., Lin, Y., Anrather, J., Csizmadia, E., Takigami, K., Sato, K., Grey, S.T., Colvin, R.B., Choi, A.M., Poss, K.D., and Bach, F.H. (1998). Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 4, 1073-1077.
54. Tenhunen, R., Marver, H.S., and Schmid, R. (1968). The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A. 61, 748-755.
55. Tran, P.L., Weinbach, J., Opolon, P., Linares-Cruz, G., Reynes, J.P., Gregoire, A., Kremer, E., Durand, H., and Perricaudet, M. (1997). Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. J. Clin. Invest. 99, 608-617.
56. Wang, H.D., Yamaya, M., Okinaga, S., Jia, Y.X., Kamanaka, M., Takahashi, H., Guo, L.Y., Ohrui, T., and Sasaki, H. (2002). Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am. J. Respir. Crit. Care Med. 165, 406-411.
57. Wang, R., Ibarra-Sunga, O., Verlinski, L., Pick, R., and Uhal, B.D. (2000). Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L143-L151.
58. Westergren-Thorsson, G., Hernnas, J., Sarnstrand, B., Oldberg, A., Heinegard, D., and Malmstrom, A. (1993). Altered expression of small proteoglycans, collagen, and transforming growth factor-β1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 92, 632-637.
59. Willis, D., Moore, A.R., Frederick, R., and Willoughby, D.A. (1996). Heme oxygenase: A novel target for the modulation of the inflammatory response. Nat. Med. 2, 87-90.
60. Woessner, J.F. (1961). The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 93, 440-447.
61. Ziesche, R., Hofbauer, E., Wittmann, K., Petkov, V., and Block, L.H. (1999). A preliminary study of long-term treatment with interferon γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 341, 1264-1269.